Plansulin

Plansulin is developing a plant-based approach to insulin production aimed at reducing costs, environmental impact, and increasing accessibility. It outlines the global diabetes crisis, noting that over 463 million people currently live with diabetes — a number expected to reach 700 million by 2045 — and highlights the challenge of expensive and unsustainable traditional insulin manufacturing. The company's eco-friendly plant-derived insulin alternative is purported to cut production costs by up to 40%, while maintaining quality and meeting global demand. Ultimately, it aims to transform the insulin market through sustainable plant-based pharmaceuticals via global partnerships and localized production facilities.